INMUNE BIO, INC.

Analyst Reco. INmune Bio, Inc.

Equities

INMB

US45782T1051

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
10.62 ^USD	+4.73%		+25.98%	-5.68%

Apr. 23	Inmune Bio Inc. Announces 24-Month Stability Validation of Xpro? for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay	CI
Apr. 08	INmune Bio Inc. Presents Data on INB03's Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Initiates INmune Bio at Outperform With $16 Price Target	23-06-01	MT
INmune Bio Shares Rebound From 52-Week Low, Up 9%	22-05-25	DJ
INmune Bio Shares Hit 52-Week Low After FDA Requests More Data on XPro1595	22-05-24	DJ
BTIG Adjusts INmune Bio's Price Target to $14 From $31, Reiterates Buy Rating	22-05-24	MT
B. Riley Downgrades INmune Bio to Neutral from Buy on Chemistry Manufacturing and Controls-Related FDA Hold, Lowers Price Target to $7 from $14	22-05-24	MT
B. Riley Lowers INmune Bio's Price Target to $14 from $20, Notes Higher Cost of Capital; Keeps Buy Rating	22-03-08	MT
B. Riley Lowers INmune Bio's Price Target to $20 from $32 After Revising Cost Capital Assumptions, Keeps Buy Rating	22-01-24	MT
INMUNE BIO : B. Riley Raises INmune Bio's PT to $32 from $26, Notes 'Encouraging' Datasets From 2 Lead Programs; Keeps Buy Rating	21-09-07	MT
INMUNE BIO : B. Riley Lowers INmune Bio's PT to $26 from $34 on Revised Costs and Timeline for AD Development, Keeps Buy Rating	21-08-06	MT
INMUNE BIO : B. Riley Raises INmune Bio's PT to $34 from $29 Driven by Pipeine Progress, Simplification of Capital Structure; Keeps Buy Rating	21-07-14	MT
INMUNE BIO : B. Riley Starts INmune Bio at Buy with $29 PT; Says Breast Cancer, Alzheimer's Programs Represent Potential Upside to Model	21-04-21	MT
INMUNE BIO : HC Wainwright Adjusts INmune Bio's Price Target to $15 from $20, Keeps Buy Rating	20-11-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer